Sun Pharma site hit with second Form 483 in 3 years

An Indian pharma with a manufacturing site in Gujarat has been slapped with a Form 483 from the FDA after inspections that ended yesterday resulted in 10 observations.

The inspection was carried out from April 26 to May 9 at Sun Pharma’s Halol facility in Gujarat,...

Click to view original post